: In animal models, 287_63 was identified as one of the top-performing "anti-fibrotic" materials. It significantly reduced the formation of scar tissue around implants.
"287_63" refers to a specific chemical identifier—specifically —used in groundbreaking research on modified alginate polymers to prevent the foreign body response (fibrosis) in medical implants. Research Context 287_63
: Highly cited papers in Nature Medicine and Nature Biotechnology (circa 2016) by the Anderson and Langer labs. : In animal models, 287_63 was identified as
: It is a core component of U.S. Patent 10,898,443 and U.S. Patent 11,337,930 , which describe methods for making and using these modified alginates for cell therapy. ( 12 ) United States Patent - Googleapis.com : In animal models